Free release
Lithium 3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)pyrr

Lithium 3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)pyrr

CAS No. :1449413-05-1MDL No. :MFCD30609551Formula :C24H22LiN7O4Boiling Point :-Linear Structure Formula :-InChI Key :WKF

Sales:Service@apichina.com
CAS No. :1449413-05-1 Brand :Qitai
Formula :C24H22LiN7O4 M.W :479.42

Introduction

CAS No. :1449413-05-1 MDL No. :MFCD30609551
Formula : C24H22LiN7O4 Boiling Point : -
Linear Structure Formula :- InChI Key :WKFLNWYUJVFROC-UHFFFAOYSA-M
M.W : 479.42 Pubchem ID :71680007
Synonyms :

Physicochemical Properties

Num. heavy atoms : 36
Num. arom. heavy atoms : 20
Fraction Csp3 : 0.25
Num. rotatable bonds : 7
Num. H-bond acceptors : 8.0
Num. H-bond donors : 0.0
Molar Refractivity : 132.28
TPSA : 123.41 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : -11.11
Log Po/w (XLOGP3) : 1.7
Log Po/w (WLOGP) : 0.5
Log Po/w (MLOGP) : 0.02
Log Po/w (SILICOS-IT) : 1.72
Consensus Log Po/w : -1.44

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.83
Solubility : 0.0705 mg/ml ; 0.000147 mol/l
Class : Soluble
Log S (Ali) : -3.91
Solubility : 0.0594 mg/ml ; 0.000124 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.58
Solubility : 0.00126 mg/ml ; 0.00000264 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.58
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram: